Warning: The NCBI web site requires JavaScript to function. more...
Therapeutic challenges in hepatitis C-infected injection drug using patients.
Cooper CL, Mills EJ.
Harm Reduct J. 2006 Nov 10;3:31.
Related citations
Obstacles to successful HCV treatment in substance addicted patients.
Cooper CL.
J Addict Dis. 2008;27(2):61-8. Review.
Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care.
Sylvestre DL, Loftis JM, Hauser P, Genser S, Cesari H, Borek N, Kresina TF, Seeff L, Francis H.
J Urban Health. 2004 Dec;81(4):719-34.
Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.
Xia X, Luo J, Bai J, Yu R.
Public Health. 2008 Oct;122(10):990-1003. Epub 2008 May 19. Review.
Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.
Fischer B, Haydon E, Rehm J, Krajden M, Reimer J.
J Urban Health. 2004 Sep;81(3):428-47.
Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.
Int J Drug Policy. 2007 Oct;18(5):417-25. Epub 2007 Feb 20. Review.
Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection.
Grebely J, Genoway K, Khara M, Duncan F, Viljoen M, Elliott D, Raffa JD, DeVlaming S, Conway B.
Int J Drug Policy. 2007 Oct;18(5):437-43. Epub 2007 Apr 27.
Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.
Seeff LB, Hoofnagle JH.
Clin Liver Dis. 2003 Feb;7(1):261-87. Review.
A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users.
Mehta SH, Thomas DL, Sulkowski MS, Safaein M, Vlahov D, Strathdee SA.
AIDS. 2005 Oct;19 Suppl 3:S179-89. Review.
[Prevention and treatment of hepatitis C in illicit drug users].
Sakoman S.
Acta Med Croatica. 2009 Dec;63(5):437-42. Croatian.
Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?
Schaefer M, Heinz A, Backmund M.
Addiction. 2004 Sep;99(9):1167-75. Review.
Evaluation of a general practice based hepatitis C virus screening intervention.
Anderson EM, Mandeville RP, Hutchinson SJ, Cameron SO, Mills PR, Fox R, Ahmed S, Taylor A, Spence E, Goldberg DJ.
Scott Med J. 2009 Aug;54(3):3-7.
Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
Santana Rodríguez OE, Malé Gil ML, HernándezSantana JF, Limiñana Cañal JM, Martín Sánchez AM.
Eur J Epidemiol. 1998 Sep;14(6):555-61.
Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Bird SM, Goldberg DJ, Hutchinson SJ.
J Epidemiol Biostat. 2001;6(3):243-65; discussion 279-85.
Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users.
Li JR, Gong RY, Tian KL, Wang J, Wang YX, Huang HJ.
World J Gastroenterol. 2007 Apr 28;13(16):2357-62.
Hepatitis C virus infection in Scotland: epidemiological review and public health challenges.
Hutchinson SJ, Roy KM, Wadd S, Bird SM, Taylor A, Anderson E, Shaw L, Codere G, Goldberg DJ.
Scott Med J. 2006 May;51(2):8-15. Review.
Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients.
Novick DM, Kreek MJ.
Addiction. 2008 Jun;103(6):905-18. Epub 2008 Apr 16. Review.
Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
Liu JY, Lin HH, Liu YC, Lee SS, Chen YL, Hung CC, Ko WC, Huang CK, Lai CH, Chen YS, Shih YL, Chung HC, Liang SH, Lin JN.
Clin Infect Dis. 2008 Jun 1;46(11):1761-8.
Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: insights from the ATAHC study.
Nguyen OK, Dore GJ, Kaldor JM, Hellard ME; ATAHC Protocol Steering Committee.
Int J Drug Policy. 2007 Oct;18(5):447-51. Epub 2007 Feb 21.
The impact of injecting drug use status on hepatitis C-related referral and treatment.
Stoové MA, Gifford SM, Dore GJ.
Drug Alcohol Depend. 2005 Jan 7;77(1):81-6.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on